High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial (Q57904758)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 November 2007

Language	Label	Description	Also known as
English	High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial	scientific article published on 19 November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Achilles Anagnostopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Georgios D Vlachos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Athanasios Dimopoulos

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Papadimitriou C

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Voulgaris Z

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Rodolakis A

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Aravantinos G

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Bamias A

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Kiosses E

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Gourgoulis GM

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Efstathiou E

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

0 references

publication date

19 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

547-554

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

High dose chemotherapy in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Ovarian carcinoma. A decade of progress

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in the management of gynecologic cancer: consensus summary statement

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705925

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705925

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026149 AND SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57904758&oldid=2213669874"